Electrophysiology – News and Features

This trial is important because it is one of the first to examine a methodology for personalizing cancer treatment.

The event will feature five major sections this year, including New Targets, Drug Discovery Approaches, Channelopathies, CNS & Neurodegeneration and Technologies.

The QPatch will allow researchers to perform high-quality ion channel pharmacological and biophysical experiments.

The collaboration aims to complete the QPatch HT, a 48-channel automated, gigaseal patch clamp system.

Nanion received the award for its chip-based patch clamp technique.

BioFocus has appointed Dr Iain James as Director of Biology and has commissioned an IonWorks Quattro™ high-throughput electrophysiology screening system.

Axon Instruments, Inc. and Aviva Biosciences Corp. announced an exclusive agreement to collaborate on the development and commercialization of a Patch-on-a-Chip™ planar electrode device for use in Axon's PatchXpress ion channel drug screening systems.